| John G Van Gilder, MD | |
|
401 15th Ave S, 101, Great Falls, MT 59405 | |
| (406) 452-9504 | |
| (406) 761-3192 |
| Full Name | John G Van Gilder |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 28 Years |
| Location | 401 15th Ave S, Great Falls, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437233269 | NPI | - | NPPES |
| 0063682 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 10372 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Benefis Hospitals Inc | Great falls, MT | Hospital |
| Great Falls Clinic Hospital | Great falls, MT | Hospital |
| Pondera Medical Center | Conrad, MT | Hospital |
| St Peters Hospital | Helena, MT | Hospital |
| Entity Name | John G Vangilder Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689915456 PECOS PAC ID: 6204071830 Enrollment ID: O20130401000499 |
News Archive
Most Americans know about MyPyramid - the triangle depicting how many servings of each food group you should eat in a day - but who knows about MyPlate - the circle showing what a healthy meal looks like? MyPlate was created in 2011 by the United States Department of Agriculture (USDA) to help American consumers put the Dietary Guidelines into practice. It's a simple, colorful icon that prompts us to think about what's on our plate, illustrating healthy proportions of fruit, vegetables, grains, protein, and dairy within a single meal.
Today it was announced that Ronald McDonald House Toronto (RMH Toronto) received an $8.7 million capital grant towards building a new House from the Government of Canada, as part of a joint Canada-Ontario investment.
A research team in the Netherlands has found that cells from burn eschar, the non-viable tissue remaining after burn injury and normally removed to prevent infection, can be a source of mesenchymal cells that may be used for tissue engineering.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer therapeutics using its Targeted Antibody Payload technology, disclosed for the first time today preclinical data for its EGFR-targeting ADC, IMGN289.
Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John G Van Gilder, MD 401 15th Ave S, 101, Great Falls, MT 59405 Ph: (406) 452-9504 | John G Van Gilder, MD 401 15th Ave S, 101, Great Falls, MT 59405 Ph: (406) 452-9504 |
News Archive
Most Americans know about MyPyramid - the triangle depicting how many servings of each food group you should eat in a day - but who knows about MyPlate - the circle showing what a healthy meal looks like? MyPlate was created in 2011 by the United States Department of Agriculture (USDA) to help American consumers put the Dietary Guidelines into practice. It's a simple, colorful icon that prompts us to think about what's on our plate, illustrating healthy proportions of fruit, vegetables, grains, protein, and dairy within a single meal.
Today it was announced that Ronald McDonald House Toronto (RMH Toronto) received an $8.7 million capital grant towards building a new House from the Government of Canada, as part of a joint Canada-Ontario investment.
A research team in the Netherlands has found that cells from burn eschar, the non-viable tissue remaining after burn injury and normally removed to prevent infection, can be a source of mesenchymal cells that may be used for tissue engineering.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer therapeutics using its Targeted Antibody Payload technology, disclosed for the first time today preclinical data for its EGFR-targeting ADC, IMGN289.
Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.
› Verified 8 days ago
Kristin Huntoon, D.O, PHD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-455-5000 Fax: 406-731-8318 | |
Paul L Gorsuch Jr., MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 15th Ave S, #101, Great Falls, MT 59405 Phone: 406-761-3181 Fax: 406-761-3192 | |
Dr. Dale Michael Schaefer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 28th St S, Suite 7, Great Falls, MT 59405 Phone: 406-454-0375 Fax: 406-454-0377 | |
Benny Earl Brandvold, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-455-5000 Fax: 406-731-8318 | |
Richard J Teff, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8318 |